RxDoctor Payments DataLook up a doctor →

ZEPBOUND: payments to doctors

Payments that named ZEPBOUND as the associated drug or biological, reported under the Sunshine Act for program years 20192025.

Total reported
$19.8M
Providers
97,317
Transactions
360,176
Average per transaction
$55

The per-transaction average — $55 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 97,317 providers the average total is $203, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
Lilly USA, LLC$19,564,12098.9%
Eli Lilly$205,8391.0%
Eli Lilly Export S.A. Puerto Rico Branch$17,6360.1%
← All drugs & devices